pmid	doi	year	title	Hugo_Symbol
34260908	10.1016/j.celrep.2021.109372	2021	Inhibition of Rag GTPase signaling in mice suppresses B cell responses and lymphomagenesis with minimal detrimental trade-offs.	RRAGC
31579886	10.1038/s42255-019-0098-8	2019	Oncogenic Rag GTPase signaling enhances B cell activation and drives follicular lymphoma sensitive to pharmacological inhibition of mTOR.	RRAGC
28659443	10.1126/scitranslmed.aak9969	2017	Genetic and epigenetic inactivation of <i>SESTRIN1</i> controls mTORC1 and response to EZH2 inhibition in follicular lymphoma.	RRAGC
26691987	10.1038/ng.3473	2016	Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.	RRAGC
27230687	10.1038/ng0616-700b	2016	Corrigendum: Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma.	RRAGC
27267853	10.1158/1078-0432.CCR-16-0609	2016	Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma.	RRAGC
